Patients - Derived xenografts (PDX) are models of cancer in which tumors from patients with the above tissues or cells are injected into one or immunodeficient humanized mice. The PDX model mimics human tumor biology, allowing natural cancer progression and providing the most transformative research models to assess efficacy.
The Patient Derived Xenograft or PDX Models market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.
Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.
In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Patient Derived Xenograft or PDX Models industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.
The Patient Derived Xenograft or PDX Models market can be split based on product types, major applications, and important countries as follows:
Key players in the global Patient Derived Xenograft or PDX Models market covered in Chapter 12:
Epo Berlin-Buch Gmbh
Charles River Laboratories International Inc.
Xentech
Hera Biolabs
Crown Bioscience Inc.
The Jackson Laboratory
Shanghai Lide Biotech Co. Ltd. (China)
Oncodesign
Champions Oncology Inc.
Pharmatest Services Ltd.
Wuxi Apptec (Group of Subsidiaries Under Wuxi Pharmatec)
Horizon Discovery Group Plc (Sage Labs Inc.)
Urolead
Bioduro (Us)
Xenopat (Spain)
In Chapter 4 and 14.1, on the basis of types, the Patient Derived Xenograft or PDX Models market from 2015 to 2025 is primarily split into:
Mice Models
Rat Models
In Chapter 5 and 14.2, on the basis of applications, the Patient Derived Xenograft or PDX Models market from 2015 to 2025 covers:
Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Academic & Research Institutions
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Table of Content
1 Patient Derived Xenograft or PDX Models Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Patient Derived Xenograft or PDX Models
1.3 Scope of The Study
1.3.1 Key Market Segments
1.3.2 Players Covered
1.3.3 COVID-19's impact on the Patient Derived Xenograft or PDX Models industry
1.4 Methodology of The Study
1.5 Research Data Source
2 Executive Summary
2.1 Market Overview
2.1.1 Global Patient Derived Xenograft or PDX Models Market Size, 2015 - 2020
2.1.2 Global Patient Derived Xenograft or PDX Models Market Size by Type, 2015 - 2020
2.1.3 Global Patient Derived Xenograft or PDX Models Market Size by Application, 2015 - 2020
2.1.4 Global Patient Derived Xenograft or PDX Models Market Size by Region, 2015 - 2025
2.2 Business Environment Analysis
2.2.1 Global COVID-19 Status and Economic Overview
2.2.2 Influence of COVID-19 Outbreak on Patient Derived Xenograft or PDX Models Industry Development
3 Industry Chain Analysis
3.1 Upstream Raw Material Suppliers of Patient Derived Xenograft or PDX Models Analysis
3.2 Major Players of Patient Derived Xenograft or PDX Models
3.3 Patient Derived Xenograft or PDX Models Manufacturing Cost Structure Analysis
3.3.1 Production Process Analysis
3.3.2 Manufacturing Cost Structure of Patient Derived Xenograft or PDX Models
3.3.3 Labor Cost of Patient Derived Xenograft or PDX Models
3.4 Market Distributors of Patient Derived Xenograft or PDX Models
3.5 Major Downstream Buyers of Patient Derived Xenograft or PDX Models Analysis
3.6 The Impact of Covid-19 From the Perspective of Industry Chain
3.7 Regional Import and Export Controls Will Exist for a Long Time
3.8 Continued downward PMI Spreads Globally
4 Global Patient Derived Xenograft or PDX Models Market, by Type
4.1 Global Patient Derived Xenograft or PDX Models Value and Market Share by Type (2015-2020)
4.2 Global Patient Derived Xenograft or PDX Models Production and Market Share by Type (2015-2020)
4.3 Global Patient Derived Xenograft or PDX Models Value and Growth Rate by Type (2015-2020)
4.3.1 Global Patient Derived Xenograft or PDX Models Value and Growth Rate of Mice Models
4.3.2 Global Patient Derived Xenograft or PDX Models Value and Growth Rate of Rat Models
4.4 Global Patient Derived Xenograft or PDX Models Price Analysis by Type (2015-2020)
5 Patient Derived Xenograft or PDX Models Market, by Application
5.1 Downstream Market Overview
5.2 Global Patient Derived Xenograft or PDX Models Consumption and Market Share by Application (2015-2020)
5.3 Global Patient Derived Xenograft or PDX Models Consumption and Growth Rate by Application (2015-2020)
5.3.1 Global Patient Derived Xenograft or PDX Models Consumption and Growth Rate of Pharmaceutical & Biotechnology Companies (2015-2020)
5.3.2 Global Patient Derived Xenograft or PDX Models Consumption and Growth Rate of Contract Research Organizations (2015-2020)
5.3.3 Global Patient Derived Xenograft or PDX Models Consumption and Growth Rate of Academic & Research Institutions (2015-2020)
6 Global Patient Derived Xenograft or PDX Models Market Analysis by Regions
6.1 Global Patient Derived Xenograft or PDX Models Sales, Revenue and Market Share by Regions
6.1.1 Global Patient Derived Xenograft or PDX Models Sales by Regions (2015-2020)
6.1.2 Global Patient Derived Xenograft or PDX Models Revenue by Regions (2015-2020)
6.2 North America Patient Derived Xenograft or PDX Models Sales and Growth Rate (2015-2020)
6.3 Europe Patient Derived Xenograft or PDX Models Sales and Growth Rate (2015-2020)
6.4 Asia-Pacific Patient Derived Xenograft or PDX Models Sales and Growth Rate (2015-2020)
6.5 Middle East and Africa Patient Derived Xenograft or PDX Models Sales and Growth Rate (2015-2020)
6.6 South America Patient Derived Xenograft or PDX Models Sales and Growth Rate (2015-2020)
7 North America Patient Derived Xenograft or PDX Models Market Analysis by Countries
7.1 The Influence of COVID-19 on North America Market
7.2 North America Patient Derived Xenograft or PDX Models Sales, Revenue and Market Share by Countries
7.2.1 North America Patient Derived Xenograft or PDX Models Sales by Countries (2015-2020)
7.2.2 North America Patient Derived Xenograft or PDX Models Revenue by Countries (2015-2020)
7.3 United States Patient Derived Xenograft or PDX Models Sales and Growth Rate (2015-2020)
7.4 Canada Patient Derived Xenograft or PDX Models Sales and Growth Rate (2015-2020)
7.5 Mexico Patient Derived Xenograft or PDX Models Sales and Growth Rate (2015-2020)
8 Europe Patient Derived Xenograft or PDX Models Market Analysis by Countries
8.1 The Influence of COVID-19 on Europe Market
8.2 Europe Patient Derived Xenograft or PDX Models Sales, Revenue and Market Share by Countries
8.2.1 Europe Patient Derived Xenograft or PDX Models Sales by Countries (2015-2020)
8.2.2 Europe Patient Derived Xenograft or PDX Models Revenue by Countries (2015-2020)
8.3 Germany Patient Derived Xenograft or PDX Models Sales and Growth Rate (2015-2020)
8.4 UK Patient Derived Xenograft or PDX Models Sales and Growth Rate (2015-2020)
8.5 France Patient Derived Xenograft or PDX Models Sales and Growth Rate (2015-2020)
8.6 Italy Patient Derived Xenograft or PDX Models Sales and Growth Rate (2015-2020)
8.7 Spain Patient Derived Xenograft or PDX Models Sales and Growth Rate (2015-2020)
8.8 Russia Patient Derived Xenograft or PDX Models Sales and Growth Rate (2015-2020)
9 Asia Pacific Patient Derived Xenograft or PDX Models Market Analysis by Countries
9.1 The Influence of COVID-19 on Asia Pacific Market
9.2 Asia Pacific Patient Derived Xenograft or PDX Models Sales, Revenue and Market Share by Countries
9.2.1 Asia Pacific Patient Derived Xenograft or PDX Models Sales by Countries (2015-2020)
9.2.2 Asia Pacific Patient Derived Xenograft or PDX Models Revenue by Countries (2015-2020)
9.3 China Patient Derived Xenograft or PDX Models Sales and Growth Rate (2015-2020)
9.4 Japan Patient Derived Xenograft or PDX Models Sales and Growth Rate (2015-2020)
9.5 South Korea Patient Derived Xenograft or PDX Models Sales and Growth Rate (2015-2020)
9.6 India Patient Derived Xenograft or PDX Models Sales and Growth Rate (2015-2020)
9.7 Southeast Asia Patient Derived Xenograft or PDX Models Sales and Growth Rate (2015-2020)
9.8 Australia Patient Derived Xenograft or PDX Models Sales and Growth Rate (2015-2020)
10 Middle East and Africa Patient Derived Xenograft or PDX Models Market Analysis by Countries
10.1 The Influence of COVID-19 on Middle East and Africa Market
10.2 Middle East and Africa Patient Derived Xenograft or PDX Models Sales, Revenue and Market Share by Countries
10.2.1 Middle East and Africa Patient Derived Xenograft or PDX Models Sales by Countries (2015-2020)
10.2.2 Middle East and Africa Patient Derived Xenograft or PDX Models Revenue by Countries (2015-2020)
10.3 Saudi Arabia Patient Derived Xenograft or PDX Models Sales and Growth Rate (2015-2020)
10.4 UAE Patient Derived Xenograft or PDX Models Sales and Growth Rate (2015-2020)
10.5 Egypt Patient Derived Xenograft or PDX Models Sales and Growth Rate (2015-2020)
10.6 Nigeria Patient Derived Xenograft or PDX Models Sales and Growth Rate (2015-2020)
10.7 South Africa Patient Derived Xenograft or PDX Models Sales and Growth Rate (2015-2020)
11 South America Patient Derived Xenograft or PDX Models Market Analysis by Countries
11.1 The Influence of COVID-19 on Middle East and Africa Market
11.2 South America Patient Derived Xenograft or PDX Models Sales, Revenue and Market Share by Countries
11.2.1 South America Patient Derived Xenograft or PDX Models Sales by Countries (2015-2020)
11.2.2 South America Patient Derived Xenograft or PDX Models Revenue by Countries (2015-2020)
11.3 Brazil Patient Derived Xenograft or PDX Models Sales and Growth Rate (2015-2020)
11.4 Argentina Patient Derived Xenograft or PDX Models Sales and Growth Rate (2015-2020)
11.5 Columbia Patient Derived Xenograft or PDX Models Sales and Growth Rate (2015-2020)
11.6 Chile Patient Derived Xenograft or PDX Models Sales and Growth Rate (2015-2020)
12 Competitive Landscape
12.1 Epo Berlin-Buch Gmbh
12.1.1 Epo Berlin-Buch Gmbh Basic Information
12.1.2 Patient Derived Xenograft or PDX Models Product Introduction
12.1.3 Epo Berlin-Buch Gmbh Production, Value, Price, Gross Margin 2015-2020
12.2 Charles River Laboratories International Inc.
12.2.1 Charles River Laboratories International Inc. Basic Information
12.2.2 Patient Derived Xenograft or PDX Models Product Introduction
12.2.3 Charles River Laboratories International Inc. Production, Value, Price, Gross Margin 2015-2020
12.3 Xentech
12.3.1 Xentech Basic Information
12.3.2 Patient Derived Xenograft or PDX Models Product Introduction
12.3.3 Xentech Production, Value, Price, Gross Margin 2015-2020
12.4 Hera Biolabs
12.4.1 Hera Biolabs Basic Information
12.4.2 Patient Derived Xenograft or PDX Models Product Introduction
12.4.3 Hera Biolabs Production, Value, Price, Gross Margin 2015-2020
12.5 Crown Bioscience Inc.
12.5.1 Crown Bioscience Inc. Basic Information
12.5.2 Patient Derived Xenograft or PDX Models Product Introduction
12.5.3 Crown Bioscience Inc. Production, Value, Price, Gross Margin 2015-2020
12.6 The Jackson Laboratory
12.6.1 The Jackson Laboratory Basic Information
12.6.2 Patient Derived Xenograft or PDX Models Product Introduction
12.6.3 The Jackson Laboratory Production, Value, Price, Gross Margin 2015-2020
12.7 Shanghai Lide Biotech Co. Ltd. (China)
12.7.1 Shanghai Lide Biotech Co. Ltd. (China) Basic Information
12.7.2 Patient Derived Xenograft or PDX Models Product Introduction
12.7.3 Shanghai Lide Biotech Co. Ltd. (China) Production, Value, Price, Gross Margin 2015-2020
12.8 Oncodesign
12.8.1 Oncodesign Basic Information
12.8.2 Patient Derived Xenograft or PDX Models Product Introduction
12.8.3 Oncodesign Production, Value, Price, Gross Margin 2015-2020
12.9 Champions Oncology Inc.
12.9.1 Champions Oncology Inc. Basic Information
12.9.2 Patient Derived Xenograft or PDX Models Product Introduction
12.9.3 Champions Oncology Inc. Production, Value, Price, Gross Margin 2015-2020
12.10 Pharmatest Services Ltd.
12.10.1 Pharmatest Services Ltd. Basic Information
12.10.2 Patient Derived Xenograft or PDX Models Product Introduction
12.10.3 Pharmatest Services Ltd. Production, Value, Price, Gross Margin 2015-2020
12.11 Wuxi Apptec (Group of Subsidiaries Under Wuxi Pharmatec)
12.11.1 Wuxi Apptec (Group of Subsidiaries Under Wuxi Pharmatec) Basic Information
12.11.2 Patient Derived Xenograft or PDX Models Product Introduction
12.11.3 Wuxi Apptec (Group of Subsidiaries Under Wuxi Pharmatec) Production, Value, Price, Gross Margin 2015-2020
12.12 Horizon Discovery Group Plc (Sage Labs Inc.)
12.12.1 Horizon Discovery Group Plc (Sage Labs Inc.) Basic Information
12.12.2 Patient Derived Xenograft or PDX Models Product Introduction
12.12.3 Horizon Discovery Group Plc (Sage Labs Inc.) Production, Value, Price, Gross Margin 2015-2020
12.13 Urolead
12.13.1 Urolead Basic Information
12.13.2 Patient Derived Xenograft or PDX Models Product Introduction
12.13.3 Urolead Production, Value, Price, Gross Margin 2015-2020
12.14 Bioduro (Us)
12.14.1 Bioduro (Us) Basic Information
12.14.2 Patient Derived Xenograft or PDX Models Product Introduction
12.14.3 Bioduro (Us) Production, Value, Price, Gross Margin 2015-2020
12.15 Xenopat (Spain)
12.15.1 Xenopat (Spain) Basic Information
12.15.2 Patient Derived Xenograft or PDX Models Product Introduction
12.15.3 Xenopat (Spain) Production, Value, Price, Gross Margin 2015-2020
13 Industry Outlook
13.1 Market Driver Analysis
13.1.2 Market Restraints Analysis
13.1.3 Market Trends Analysis
13.2 Merger, Acquisition and New Investment
13.3 News of Product Release
14 Global Patient Derived Xenograft or PDX Models Market Forecast
14.1 Global Patient Derived Xenograft or PDX Models Market Value & Volume Forecast, by Type (2020-2025)
14.1.1 Mice Models Market Value and Volume Forecast (2020-2025)
14.1.2 Rat Models Market Value and Volume Forecast (2020-2025)
14.2 Global Patient Derived Xenograft or PDX Models Market Value & Volume Forecast, by Application (2020-2025)
14.2.1 Pharmaceutical & Biotechnology Companies Market Value and Volume Forecast (2020-2025)
14.2.2 Contract Research Organizations Market Value and Volume Forecast (2020-2025)
14.2.3 Academic & Research Institutions Market Value and Volume Forecast (2020-2025)
14.3 Patient Derived Xenograft or PDX Models Market Analysis and Forecast by Region
14.3.1 North America Market Value and Consumption Forecast (2020-2025)
14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
14.3.5 South America Market Value and Consumption Forecast (2020-2025)
15 New Project Feasibility Analysis
15.1 Industry Barriers and New Entrants SWOT Analysis
15.1.1 Porter